News & Events
Rituximab in multiple sclerosis
A retrospective study of rituximab use in MS shows evidence for its safety and effectiveness
Social cognition in multiple sclerosis
People with MS display increased deficiencies in social cognition
Geographical latitude and the onset of MS
People from countries with higher latitudes are found to have an earlier onset of MS
Further evidence for effectiveness of alemtuzumab
Study shows alemtuzumab can improve pre-existing disability in relapsing-remitting MS
MSIF in Latin America
Earlier this month our CEO Peer Baneke and Head of Capacity Building Zoe Burr travelled to Buenos…
Month of the caregiver in India
For the last 19 years the MS Society of India’s Chennai Chapter has marked the 'Month of…
MS Australia marks national caregivers week with a “thank you”
MS Australia joined forced with other organisations to recognise caregivers
Evelyn Nicholson International Caregiver award 2016
MSIF’s Evelyn Nicholson award helps to recognise the importance of volunteer caregivers in the MS community
Resources for caregivers
We’re collecting resources for caregivers from around the world
Can specialised eye assessments monitor MS activity and attacks?
Researchers assess whether changes in the retina can be used as a marker of MS activity
Alemtuzumab vs interferon in relapsing remitting MS
Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS
Hormone replacement therapy could improve physical quality of life for women with MS
Researchers note a relationship between HRT and quality of life in women with MS after menopause